Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.2467
H.R.2467: To grant certain patent rights for certain nonsteroidal anti-inflammatory drugs for a 2-year period.
About This Bill
- This bill was introduced in the 104th Congress
- This bill is primarily about government operations and politics
- Introduced Oct. 11, 1995
- Latest Major Action Nov. 6, 1995
Bill Sponsor
Bill Cosponsors
5 (3 Democrats, 2 Republicans)
Bill Summary
Entitles the owner of the right to market a nonsteroidal anti-inflammatory drug that contains a previously patented active agent, that has been reviewed by the Food and Drug Administration (FDA) for more than 120 months as a new drug application, and that was approved as safe and effective by the FDA on October 29, 1992, to exclude others from making, using, offering for sale, selling, or importing into the United States such active agent for...
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
|
Sponsor introductory remarks on measure.
|
|
|
Referred to the Committee on the Judiciary, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
|
|
Referred to House Commerce
|
|
|
Referred to House Judiciary
|
|
|
Referred to the Subcommittee on Health and Environment, for a period to be subsequently determined by the Chairman.
|
|
|
Referred to the Subcommittee on Courts and Intellectual Property.
|
|
| Oct. 11, 1995 |
Introduced in the House by J. Dennis Hastert (R-Ill.) |